Page 26 - AN-2-2

Advanced Neurology A novel approach to mitigate muscle atrophy in GBS

81. Bourre JM, Pascal G, Durand G, et al., (1984), Alterations 85. Wang X, Zhao X, Mao ZY, et al., (2003), Neuroprotective
in the fatty acid composition of rat brain cells (neurons, effect of docosahexaenoic acid on glutamate-induced
astrocytes, and oligodendrocytes) and of subcellular cytotoxicity in rat hippocampal cultures. Neuroreport,
fractions (myelin and synaptosomes) induced by a diet 14: 395–401.
devoid of n‐3 fatty acids. J Neurochem, 43: 342–348. https://doi.org/10.1097/00001756-200312190-00033
https://doi.org/10.1111/j.1471-4159.1984.tb00906.x 86. Puthucheary ZA, Rawal J, McPhail M, et al., (2013),
82. Tatsumi Y, Kato A, Sango K, et al., (2019), Omega-3 Acute skeletal muscle wasting in critical illness. JAMA,
polyunsaturated fatty acids exert anti-oxidant effects 310: 1591–1600.
through the nuclear factor (erythroid-derived 2)-related https://doi.org/10.1001/jama.2013.278481
factor 2 pathway in immortalized mouse Schwann cells.
J Diabetes Investig, 10: 602–612. 87. Abu-Rumeileh S, Abdelhak A, Foschi M, et al., (2021),
Guillain-Barré syndrome spectrum associated with
https://doi.org/10.1111/jdi.12931 COVID-19: An up-to-date systematic review of 73 cases.
83. Doble A, (1999), The role of excitotoxicity in J Neurol, 268: 1133–1170.
neurodegenerative disease: Implications for therapy. https://doi.org/10.1007/s00415-020-10124-x
Pharmacol Ther, 81: 163–221.
88. Zhang AC, De Silva ME, MacIsaac RJ, et al., (2020),
84. Michael-Titus AT, (2007), Omega-3 fatty acids and Omega-3 polyunsaturated fatty acid oral supplements for
neurological injury. Prostaglandins Leukot Essent Fat Acids, improving peripheral nerve health: A systematic review and
77: 295–300. meta-analysis. Nutr Rev, 78: 323–341.
https://doi.org/10.1016/j.plefa.2007.10.021 https://doi.org/10.1093/nutrit/nuz054

Volume 2 Issue 2 (2023) 12 https://doi.org/10.36922/an.280